Table 4 γ-H2AX intensity in CD45 + CD3+ lymphocytes, CD45 + CD14 + CD15- monocytes and CD45 + CD3-myeloid cells
Parameter | N | Before CT Day 0 Mean (SE) | 30Â minutes after CT Day 0 Mean (SE) | Increase | P value |
CD45 + CD3+ lymphocytes | STF (n = 14) | 75.5 (4.7) | 89.5 (6.5) | ↑ | 0.020 |
Non-STF (n = 6) | 78.8 (5.6) | 95.7 (5.9) | ↑ | 0.001 | |
CD45 + CD14 + CD15- monocytes | STF (n = 12) | 162.2 (11.9) | 192.5 (14.3) | = | 0.055 |
Non-STF (n = 6) | 180.8 (15.6) | 206.2 (20.8) | = | 0.051 | |
CD45 + CD13- myeloid cells | STF (n =14) | 104.0 (7.0) | 109.5 (8.4) | = | 0.594 |
Non-STF (n = 6) | 109.0 (7.8) | 123.0 (6.7) | ↑ | 0.009 | |
Parameter | N | Before CT Day 0 Median (range) | 7Â days after CT Median (range) | Increase | P value |
CD45 + CD3+ lymphocytes | STF (n =16) | 75.5 (49–157) | 83.0 (64–141) | = | 0.109 |
Non-STF (n = 9) | 78.0 (47–102) | 90.0 (71–114) | ↑ | 0.015 | |
CD45 + CD14 + CD15- monocytes | STF (n = 14) | 157.0 (114–231) | 186.5 (132–295) | ↑ | 0.035 |
Non-STF (n = 8) | 203.5 (116–273) | 258.5 (183–319) | ↑ | 0.021 | |
CD45 + CD13- myeloid cells | STF (n = 16) | 106.0 (71–173) | 84.0 (65–145) | = | 0.379 |
Non-STF (n = 9) | 88.0 (49–137) | 88.0 (74–119) | = | 0.477 |